Pharmacist-led diabetes disease management: We get to cruise control
This is Part 2 of the story of Sandra Leal, PharmD. Part 1
described her care for an older woman, Maria, at the El Rio Community Health
Center, a Federally Qualified Health Center.
Sandra’s program received the Pinnacle Award in September 2014 from the
American Pharmacists Association.
We’re in
medical suites, like the other medical providers. We have appointments for patients who are
referred to us for trouble with the control of their diabetes, or who’re
struggling to get control, or starting insulin, and have issues with that, e.g.,
insulin resistance, being afraid of that, etc., so we try to spend a lot of
time on the best medication regimen.
With Maria, I spent about 25 minutes yesterday to do an a1C, review her
immunizations, and have her vital signs done by a Medical Assistant. We’re a Diabetes Self-Management Training
Site, and a Federally Qualified Health Center, so we have double accreditation,
and get paid by Medicare for people like Maria, though here in Arizona, not by
Medicaid.
We’ll handle
issues like affordability, complexity of the regimen, and how to fit it into
their life. That’s a big challenge when
they’re taking multiple medications for diabetes, usually coupled with
cholesterol, nerve pain, depression, etc.
So they take six to twelve medications. That’s a usual amount. Yesterday 1 had a woman who was taking 18
meds. Even WITH health insurance, $15
times six to twelve medications is amazingly expensive and unaffordable. I really try to customize the regimen for
their lifestyle. I really listen to their
needs, and work with them.
For providers,
our automatic trigger is to increase and add another medication. But it’s better to see why they’re not taking
it. My role as a pharmacist is to focus
on that, and really delve into the barriers.
That’s my specialty, which is often overlooked by other medical
providers. Often they’ll send people to
the pharmacy just to dispense medication.
The most
common barriers are not understanding the importance of taking the medication
and what it could do for her. I really
spend a lot of time with each medication and what it’d do, connecting it to the
lab values. They might complain about
having to go to the bathroom a lot, fatigue, etc. So I’ll emphasize that they’ll have more
energy, and won’t have to get up three times in the night to go to the
bathroom. A lot of times it clicks with
people, so they don’t say any longer, I don’t want to take them at all. We connect the dots for them. We’ll compromise. Once we have one success, they come back,
asking what else can we do?
We have a
Collaborative Practice Agreement, so I can initiate insulin, order labs, and
generate a referral to other providers.
That makes it more efficient. We
document what we do in the electronic medical record. We’re med reconciling, adding the mammogram,
recoding about the colonoscopy, etc.
That frees up time for the doctor to focus with the patient. Providers in this model really work
well: it’s more efficient and effective
for the patient, because their needs are addressed.
For a patient
like Maria with Type 2 diabetes, her next a1C test is due in three months, so
she should come back then. After that,
when we get to “cruise control,” I’ll see her every six months. When she comes back, we’ll take care of a lot
of other issues too, e.g., an eye exam, foot exam, and immunizations. I’ll make sure we’re doing those on a yearly
basis. We do eye screening here. That
used to be a barrier to find transportation, so we worked with a local
ophthalmologist to have screening on site.
If a patient
has another chronic condition, like pain management or depression, we’re
basically triaging things for which they should see another provider. We’d send the patient and we tell the doctor
and patient: Focus specifically on depression.
We write it down for the patient:
Your next visit is for depression specifically, because this is
impacting your ability to do other things.
Thanks to Sandra Leal, PharmD, MPH, FAPhA, CDE for
sharing her story. Sandra is the Medical
Director of Clinical Pharmacists. Maria
is a pseudonym.
Read another story about diabetes care.
No comments:
Post a Comment